NYSEAMERICAN:NSRX Nasus Pharma Q2 2026 Earnings Results & Report $2.91 -0.07 (-2.35%) Closing price 04:10 PM EasternExtended Trading$2.94 +0.03 (+1.03%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Nasus Pharma reported Q2 2026 earnings on August 17, 2026. The company reported EPS of -$0.27. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 17, 2026TimeBefore Market Opens Nasus Pharma EPS ResultsActual EPS-$0.27Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ANasus Pharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Nasus Pharma Q2 2026 Earnings FAQ Did Nasus Pharma beat earnings estimates for Q2 2026? Nasus Pharma (NYSEAMERICAN:NSRX) reported earnings of -$0.27 per share for Q2 2026. The report was announced on Monday, August 17, 2026. Nasus Pharma Earnings HeadlinesNasus Pharma consensus price target decreased by 25.42% to $14.96November 2, 2026 | msn.comMaxim Group Begins Coverage on Nasus Pharma (NYSEAMERICAN:NSRX)November 1, 2026 | americanbankingnews.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 11 at 1:00 AM | Profits Run (Ad)Maxim Group initiates coverage of Nasus Pharma with buyOctober 30, 2026 | msn.comNasus Pharma Ltd (NSRX)October 20, 2026 | investing.comNasus Pharma Shareholders Approve Most Proposals at October Annual and Special MeetingOctober 8, 2026 | tipranks.comSee More Nasus Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nasus Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nasus Pharma and other key companies, straight to your email. Email Address About Nasus PharmaNasus Pharma (NYSEAMERICAN:NSRX) is a specialty pharmaceutical company focused on developing intranasal powder-based medicines. Its proprietary platform is designed to deliver drug therapies through the nose, with the potential to support rapid administration without the need for injections or other conventional delivery methods. The company’s development efforts are directed toward acute and emergency-care applications, including treatments for conditions in which rapid drug delivery may be important. Nasus Pharma has described its pipeline as including intranasal products intended for use in areas such as anaphylaxis, opioid overdose and other urgent medical situations. Nasus Pharma is an early-stage company, and many of its product candidates remain under development and subject to clinical, regulatory and commercial milestones. Information about its broader commercial operations, geographic reach and leadership is limited.View Nasus Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going AwayPowering Up the Moon: Redwire’s $40 Million NASA Award Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
